Methocarbamol does not raise blood pressure. The drug is a centrally acting muscle relaxant that works by dampening nerve signals in the spinal cord and brain, and its pharmacological profile leans the other way: if it nudges blood pressure at all, the shift tends to be downward, not upward. The prescribing information for methocarbamol actually lists hypotension and bradycardia among its possible cardiovascular side effects, particularly when the drug is given intravenously. Still, the question comes up often enough to deserve a closer look at what the evidence shows, why confusion exists, and what people taking methocarbamol for muscle spasms should actually worry about.
What the Evidence Says About Methocarbamol and Blood Pressure
Direct studies measuring blood pressure changes after methocarbamol dosing are limited in humans, partly because the drug has been on the market since the late 1950s and was approved under older regulatory standards that did not require the detailed cardiovascular monitoring now expected of newer medications. One of the more direct hemodynamic investigations comes from veterinary pharmacology: a study measuring cardiac output, heart rate, respiratory rate, and multiple blood pressure parameters (systolic, diastolic, mean aortic, and mean pulmonary arterial) in horses found no change in any of those values after either intravenous or oral methocarbamol at standard and high doses.1PubMed. The pharmacology and pharmacokinetics of high-dose methocarbamol in horses While horses are obviously not humans, these results are consistent with the broader clinical picture: methocarbamol simply does not have a mechanism that would push blood pressure up.
In decades of human clinical use, post-marketing surveillance and adverse event databases have not flagged hypertension as a recognized side effect of methocarbamol. The drug’s FDA-approved labeling lists dizziness, drowsiness, lightheadedness, nausea, and blurred vision as common reactions. On the cardiovascular side, it mentions hypotension (low blood pressure), bradycardia (slow heart rate), and flushing, all of which point toward a mild depressant effect on the circulatory system rather than a stimulatory one. These cardiovascular effects are more commonly reported with intravenous administration than with oral tablets.
How Methocarbamol Works and Why It Would Not Raise Blood Pressure
Methocarbamol belongs to the carbamate family of muscle relaxants. It does not act directly on muscle fibers. Instead, it depresses activity in the central nervous system, specifically in pathways that relay signals between the brain, the spinal cord, and skeletal muscles. By quieting those signals, it reduces the intensity of muscle spasms. The practical effect is sedation and muscle relaxation, which is why drowsiness is the most commonly reported side effect.
Drugs that raise blood pressure typically do so by stimulating the sympathetic nervous system (the “fight or flight” response), constricting blood vessels, increasing heart rate, or causing the body to retain fluid. Methocarbamol does none of these things. Its CNS-depressant action, if anything, mildly reduces sympathetic tone, which is why low blood pressure and a slower heart rate occasionally appear in adverse event reports. The effect is generally too small to matter clinically at standard oral doses, but it can become relevant when the drug is given intravenously or combined with other sedating substances.
Intravenous Methocarbamol and Hemodynamic Shifts
Most people encounter methocarbamol as an oral tablet, typically 500 mg or 750 mg taken several times a day. In hospital or emergency settings, however, methocarbamol can be given intravenously, and the cardiovascular picture changes somewhat with that route. IV methocarbamol is injected slowly (the labeling recommends no faster than 3 mL per minute) precisely because rapid infusion can cause a drop in blood pressure, fainting, or a slowed heartbeat. The vehicle used in the injectable formulation, polyethylene glycol 300, has itself come under scrutiny for potential toxicity at higher cumulative doses, adding another layer of caution around IV use.
For the person at home taking oral methocarbamol for a back spasm, the IV risks are not directly relevant. But they reinforce the broader pharmacological point: methocarbamol’s cardiovascular tendency is toward lowering blood pressure, not raising it. If you experience lightheadedness when standing up after taking the drug, that dip in blood pressure on position change (orthostatic hypotension) is far more consistent with methocarbamol’s known profile than any rise would be.
Why Some People Notice Higher Readings While Taking Methocarbamol
If methocarbamol itself does not raise blood pressure, why do some people report higher readings during treatment? The answer almost always lies somewhere other than the drug itself.
The most common explanation is pain. Methocarbamol is prescribed for acute musculoskeletal conditions: back spasms, neck injuries, post-surgical soreness. Pain activates the sympathetic nervous system and genuinely raises blood pressure. Someone dealing with a painful muscle injury who checks their blood pressure and sees elevated numbers may assume the new medication is responsible, when the underlying pain is the likelier culprit. In fact, by relieving muscle spasm, methocarbamol may indirectly help normalize blood pressure readings once the pain starts to subside.
Another factor is stress and anxiety. A new injury, a trip to the emergency room, worry about a diagnosis, or even the stress of taking a new medication can temporarily elevate blood pressure. These situational spikes have nothing to do with the drug’s pharmacology but are easy to misattribute if the timing coincides with starting treatment.
A third possibility involves other medications taken alongside methocarbamol. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen are frequently used for the same musculoskeletal complaints and are well documented to raise blood pressure, especially in people who already have hypertension or are taking blood pressure medications. If you started an NSAID and methocarbamol around the same time, the NSAID is a far more likely explanation for any blood pressure increase.
Drug Interactions That Actually Matter
While methocarbamol does not raise blood pressure, it does carry interaction risks worth knowing about. The most significant involves alcohol and other CNS depressants. Combining methocarbamol with alcohol, benzodiazepines, opioids, or other sedating drugs can lead to dangerously amplified sedation. A case report in the forensic literature documented a fatal interaction between methocarbamol and ethanol, noting that the combination of alcohol and carbamate-type drugs can cause severe, combined central nervous system depression due to their overlapping sedative properties.2PubMed. A fatal interaction of methocarbamol and ethanol in an accidental poisoning
This interaction matters more for blood pressure in an indirect way: profound CNS depression can cause dangerously low blood pressure, respiratory failure, or loss of consciousness. So while the concern with methocarbamol is not that it pushes blood pressure up, the drug’s sedative interactions can push blood pressure down to a degree that becomes medically dangerous when combined with other depressants.
If you are taking blood pressure medications (antihypertensives), there is no well-documented pharmacokinetic interaction with methocarbamol that would make those medications work differently. However, the additive sedative effect could compound any dizziness or lightheadedness you already experience from blood pressure drugs, especially those that also lower heart rate or relax blood vessels, like beta-blockers or calcium channel blockers. The practical advice is straightforward: be cautious about getting up quickly, driving, or operating machinery if you feel drowsy or lightheaded on the combination.
Older Adults, Falls, and the Bigger Safety Concern
For older adults, the blood pressure question is worth putting in context alongside a risk that has more evidence behind it: falls and injuries. A study of skeletal muscle relaxant use in older patients found that methocarbamol was associated with a roughly 40% increase in the odds of sustaining an injury compared to not using a muscle relaxant.3PubMed. Risk of injury associated with skeletal muscle relaxant use in older adults That risk was higher than cyclobenzaprine, another commonly prescribed muscle relaxant, and lower than carisoprodol, which carried the highest injury risk of the group studied.
The mechanism behind this injury risk is almost certainly the same CNS depression that makes methocarbamol work as a muscle relaxant. Drowsiness, impaired coordination, and slowed reflexes make older adults more likely to fall, and falls at older ages more frequently result in serious injuries like hip fractures. This is a much more concrete safety concern for older adults than any blood pressure effect. If you are over 65 and prescribed methocarbamol, the conversation with your doctor should focus on fall prevention, minimizing the dose and duration of use, and avoiding other sedating drugs at the same time.
The dizziness and lightheadedness associated with methocarbamol can contribute to fall risk in a blood-pressure-adjacent way: if the drug causes even a mild drop in blood pressure when you stand up, that orthostatic dip can cause momentary unsteadiness. Staying well hydrated, standing up slowly, and having something to hold onto can reduce that risk.
Other Muscle Relaxants That Do Affect Blood Pressure
Part of the confusion around methocarbamol and blood pressure may stem from the fact that some other drugs in the broader muscle relaxant category do have clearer effects on blood pressure. Understanding which ones do can help clarify why methocarbamol is different.
Tizanidine, for example, is an alpha-2 adrenergic agonist that lowers blood pressure as a well-recognized side effect. It was originally investigated as an antihypertensive before being repurposed as a muscle relaxant. People switching from tizanidine to methocarbamol, or taking both in sequence, might associate blood pressure changes with the wrong drug.
Baclofen, another centrally acting muscle relaxant, can cause hypotension and is known to produce rebound hypertension if stopped abruptly after long-term use. This rebound effect, where blood pressure spikes after discontinuing a drug that had been keeping it low, sometimes gets confused with a drug raising blood pressure during use.
Cyclobenzaprine is structurally related to tricyclic antidepressants and can cause tachycardia (elevated heart rate) in some people, which is occasionally accompanied by a modest blood pressure increase. If someone was previously on cyclobenzaprine and experienced higher readings, they might carry that concern forward when switched to methocarbamol, even though the two drugs work differently.
Methocarbamol, by comparison, is pharmacologically simpler. It lacks the alpha-adrenergic activity of tizanidine, the GABA-B receptor activity of baclofen, and the anticholinergic properties of cyclobenzaprine. Its side-effect profile is generally considered milder, which is one reason it remains a common first-line choice for short-term muscle spasm treatment.
What to Do If Your Blood Pressure Seems Higher
If you are taking methocarbamol and notice higher blood pressure readings, resist the urge to blame the medication before considering other explanations. A few steps can help you sort out what is actually going on:
- Check your timing: Blood pressure varies throughout the day. A reading taken during acute pain, after coffee, or while stressed will be higher than one taken while resting calmly. Try measuring at the same time each day, seated quietly for five minutes beforehand, with your arm supported at heart level.
- Review all your medications: NSAIDs, decongestants (pseudoephedrine), caffeine, and some herbal supplements can raise blood pressure. If you started any of these around the same time as methocarbamol, they are more likely suspects.
- Consider the pain itself: Uncontrolled pain is a reliable blood pressure elevator. If your muscle spasms are not yet well managed, the readings may improve as the pain does.
- Talk to your prescriber: If your blood pressure is consistently elevated (not just a single reading), bring a log of your home readings. Your doctor can evaluate whether the timing suggests a drug effect, a pain effect, or an unrelated trend that needs its own treatment.
Stopping methocarbamol on your own because of blood pressure concerns is unlikely to help and may leave your muscle spasm untreated, which could paradoxically keep your blood pressure elevated through the pain pathway. If a medication change is needed, your doctor can guide that decision with the full picture.
Kidney and Liver Considerations
People with impaired kidney or liver function sometimes worry about how methocarbamol might affect their blood pressure, since both organs play roles in blood pressure regulation and drug metabolism. Methocarbamol is metabolized primarily by the liver and excreted through the kidneys. In people with significant impairment in either organ, the drug may be cleared more slowly, leading to higher circulating levels and potentially stronger side effects, including more pronounced sedation or a greater tendency toward hypotension.
The prescribing information for methocarbamol advises caution in patients with renal impairment, particularly with the injectable form, because the polyethylene glycol vehicle is also cleared by the kidneys. For oral use, dose adjustments are not formally specified in the labeling, but many clinicians will use lower doses or shorter courses in patients with kidney or liver disease. The relevant concern in these populations remains low blood pressure and excessive sedation, not elevated blood pressure.
How Long Methocarbamol Stays in Your System
Methocarbamol has a relatively short half-life of about one to two hours, meaning it clears the body fairly quickly. Most of the drug is eliminated within 24 hours. This rapid clearance is one reason methocarbamol is typically dosed three or four times daily for muscle spasm relief. It also means that any side effects, including the mild cardiovascular effects discussed above, tend to wear off relatively quickly after the last dose.
For people concerned about blood pressure effects, the short duration of action is somewhat reassuring. Unlike medications that build up over days or weeks, methocarbamol’s impact on the body is transient. If you do experience lightheadedness or a noticeable drop in blood pressure after a dose, the effect should pass within a few hours. This is also why methocarbamol is generally prescribed for short-term use, typically two to three weeks, rather than as a long-term maintenance medication. Extended use does not appear to change the cardiovascular profile, but there is limited data on very long courses because the drug is simply not intended for chronic therapy.